EP3389699
MANNGERT, EINSTOFNA, MÓTMANNLEGT CTLA4-BLENDINGSMÓTEFNI OG NOTKUN ÞESS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.12.2016EP published:
1.5.2024EP application number:
16876612.9
EP translation filed:
31.5.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
13.12.2036Expiry date:
13.12.2026Next due date:
31.12.2026
Title in English:
CHIMERIC AND HUMANIZED ANTI-HUMAN CTLA4 MONOCLONAL ANTIBODIES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
14.12.2016EP application
1.5.2024EP Publication
31.5.2024Translation submitted
15.7.2024Registration published
13.12.2026Expires
Owner
Name:
OncoC4, Inc.Address:
9640 Medical Center Drive, Rockville, MD 20850, US
Inventor
Name:
LIU, YangAddress:
Washington, District of Columbia 20002, US
Name:
ZHENG, PanAddress:
Washington, District of Columbia 20002, US
Name:
DEVENPORT, MartinAddress:
Gaithersburg, Maryland 20878, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562267735 PDate:
15.12.2015Country:
US
Number:
201662309169 PDate:
16.3.2016Country:
US
Number:
201662359036 PDate:
6.7.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 4.11.2024
Expires: 13.12.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 4.11.2025
Expires: 13.12.2026
Payer: G.H. Sigurgeirsson ehf.